APA-referens

Navari, R. M., Rapoport, B. L., Powers, D., Arora, S., & Clark‐Snow, R. (2018). Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy. Cancer Med.

Chicago-stil citat

Navari, Rudolph M., Bernardo L. Rapoport, Dan Powers, Sujata Arora, och Rebecca Clark‐Snow. "Rolapitant for the Prevention of Nausea in Patients Receiving Highly or Moderately Emetogenic Chemotherapy." Cancer Med 2018.

MLA-referens

Navari, Rudolph M., et al. "Rolapitant for the Prevention of Nausea in Patients Receiving Highly or Moderately Emetogenic Chemotherapy." Cancer Med 2018.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.